Mian Xie

870 citations
34 papers · 700 indexed · h-index 14
Topics
Lung Cancer Treatments and Mutations (6 papers)Cancer-related molecular mechanisms research (5 papers)Hippo pathway signaling and YAP/TAZ (4 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations
ChinaUnited States

In The Last Decade

Mian Xie

30 papers receiving 691 citations

Peers

Mian Xie
Comparison fields: 5 of 75
  • Molecular Biology 356
  • Oncology 269
  • Cancer Research 144
  • Pulmonary and Respiratory Medicine 123
  • Cell Biology 102
Replace Haizeng Zhang with:
Haizeng Zhang China
Tao Bai China
Minghai Shao China
Mark V. Stevens United States
Agnese Di Rocco United States
Chunping Qiu China
Youngtae Jeong United States
Emmanuelle Saint‐Germain Canada
Francesca Reggiani Italy
Mian Xie relative to Haizeng Zhang China Haizeng Zhang's profile →
Citations per field
00.5×4.6×
Haizeng Zhang · 1×
Citations per year

Countries citing papers authored by Mian Xie

Since Specialization
Citations

This map shows the geographic impact of Mian Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mian Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mian Xie more than expected).

Fields of papers citing papers by Mian Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mian Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mian Xie. The network helps show where Mian Xie may publish in the future.

Co-authorship network of co-authors of Mian Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Mian Xie. A scholar is included among the top collaborators of Mian Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mian Xie. Mian Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 43
5 2
6 9
7 2
8 39
9 13
10 15
11 8
12 16
13 2
14 12
15 79
16 0
17 2
18 49
19 77
20 153

About Mian Xie

Mian Xie is a scholar working on Anesthesiology and Pain Medicine, Cancer Research and Family Practice, having authored 34 papers that have together received 700 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer-related molecular mechanisms research (5 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). The work is most often cited by research in Oncology (269 citations), Cancer Research (144 citations) and Cell Biology (102 citations). Mian Xie has collaborated with scholars based in China and United States. Frequent co-authors include Chaosheng He, Shenhai Wei, Fei Xu, Li Zhang, Liping Zhao, Zhihuang Hu, Junling Liu, Ying Tian, Li Zhang and Ming Liu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026